{"transactions":[{"id":2007770,"issuer":{"id":94695,"kind":"organization","name":"Rain Oncology Inc.","symbol":"RAIN"},"owners":[{"id":92988,"kind":"person","name":"Cabatuan Nelson","position":1,"cik":"0001725908","reported_name":"Cabatuan Nelson","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance & Admin"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-17T18:23:32.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":65325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 65,325 shares of the Issuer's common stock, one quarter of which will vest on February 15, 2024, with the remaining three quarters vesting in equal monthly installments through February 15, 2027, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":65325,"derivative":{"exercise_price":9.3,"expiration_date":"2033-02-15","underlying":"Common Stock","underlying_shares":65325},"source":{"system":"sec-edgar","filing":"0001104659-23-023389","document":"tm237300-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724979/000110465923023389/tm237300-1_4seq1.xml","form_type":"4"}},{"id":2411747,"issuer":{"id":94695,"kind":"organization","name":"Rain Oncology Inc.","symbol":"RAIN"},"owners":[{"id":92988,"kind":"person","name":"Cabatuan Nelson","position":1,"cik":"0001725908","reported_name":"Cabatuan Nelson","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-04T16:45:14.000Z","date":"2022-01-07","kind":"grant","acquired":true,"shares":32000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 32,000 shares of the Issuer's common stock, one quarter of which will vest on January 7, 2023, with the remaining three quarters vesting in equal monthly installments through January 7, 2026, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":32000,"derivative":{"exercise_price":12.01,"expiration_date":"2032-01-07","underlying":"Common Stock","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0000899243-22-004838","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724979/000089924322004838/doc4.xml","form_type":"4"}},{"id":2712430,"issuer":{"id":94695,"kind":"organization","name":"Rain Oncology Inc.","symbol":"RAIN"},"owners":[{"id":92988,"kind":"person","name":"Cabatuan Nelson","position":1,"cik":"0001725908","reported_name":"Cabatuan Nelson","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-14T18:37:32.000Z","date":"2021-05-12","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 6,000 shares of the Issuer's common stock, which will vest in equal monthly installments through May 12, 2025, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":6000,"derivative":{"exercise_price":15.91,"expiration_date":"2031-05-12","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0000899243-21-019568","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724979/000089924321019568/doc4.xml","form_type":"4"}},{"id":3147594,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":92988,"kind":"person","name":"Cabatuan Nelson","position":1,"cik":"0001725908","reported_name":"Cabatuan Nelson","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP,Finance & Princ.Acctg. Off."}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-16T00:57:24.000Z","date":"2020-05-14","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fifty per cent (50%) of the shares subject to the option shall vest one year from the date of grant and fifty per cent (50%) of the shares subject to the option shall vest  shall vest two years from the date of grant,  subject to the reporting person's continuous service to the issuer through each such period."}],"balance_after":20000,"derivative":{"exercise_price":1.75,"expiration_date":"2030-05-14","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001179110-20-006136","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911020006136/edgar.xml","form_type":"4"}},{"id":3284938,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":92988,"kind":"person","name":"Cabatuan Nelson","position":1,"cik":"0001725908","reported_name":"Cabatuan Nelson","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP,Finance & Princ.Acctg. Off."}}],"security":"Stock Option (right to buy)","published_at":"2020-02-07T23:31:53.000Z","date":"2020-02-06","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock subject to the option vest in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2020, subject to the reporting person's continuous service to the issuer through each such period."}],"balance_after":90000,"derivative":{"exercise_price":2.42,"expiration_date":"2030-02-06","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001179110-20-001351","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911020001351/edgar.xml","form_type":"4"}},{"id":3686941,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":92988,"kind":"person","name":"Cabatuan Nelson","position":1,"cik":"0001725908","reported_name":"Cabatuan Nelson","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-01-25T23:55:40.000Z","date":"2019-01-23","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock subject to the option vest in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2019."}],"balance_after":60000,"derivative":{"exercise_price":2,"expiration_date":"2029-01-23","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001179110-19-000940","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911019000940/edgar.xml","form_type":"4"}},{"id":3790003,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":92988,"kind":"person","name":"Cabatuan Nelson","position":1,"cik":"0001725908","reported_name":"Cabatuan Nelson","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2018-10-16T22:46:29.000Z","date":"2018-10-12","kind":"sale","acquired":false,"shares":10000,"price":3.12,"value":31200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 5, 2018."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes Reporting Person's purchases of 5,000 shares on December 29, 2017 and 5,000 shares on June 26, 2018 under the Issuer's Employee Stock Purchase Plan."}],"balance_after":58,"source":{"system":"sec-edgar","filing":"0001179110-18-012211","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911018012211/edgar.xml","form_type":"4"}},{"id":3842164,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":92988,"kind":"person","name":"Cabatuan Nelson","position":1,"cik":"0001725908","reported_name":"Cabatuan Nelson","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-08-16T22:16:24.000Z","date":"2018-08-14","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock subject to the option vest in equal monthly installments over forty-eight (48) months from the vesting commencement date of August 14, 2018."}],"balance_after":20000,"derivative":{"exercise_price":2.76,"expiration_date":"2028-08-14","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001179110-18-010636","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911018010636/edgar.xml","form_type":"4"}},{"id":4088434,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":92988,"kind":"person","name":"Cabatuan Nelson","position":1,"cik":"0001725908","reported_name":"Cabatuan Nelson","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-01-26T23:44:31.000Z","date":"2018-01-24","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock subject to the option vest in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2018."}],"balance_after":24000,"derivative":{"exercise_price":4.49,"expiration_date":"2028-01-24","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001179110-18-001146","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911018001146/edgar.xml","form_type":"4"}}]}